The introduction of next-generation technologies promises to reshape clinical practice and greatly expand options for patients who suffer from cartilage defects and degenerative joint disease.
This strategic move provides Poly Medicure with an entry point into the large global orthopedics market, particularly in the trauma and extremities segment.